Clarithromycin News
Comparative tolerability, safety and efficacy of tablet formulations of twice-daily clarithromycin 250 mg versus once-daily extended-release clarithromycin 500 mg in pediatric and adolescent patients
Clarithromycin is widely used to treat respiratory tract and superficial skin infections in pediatric and adult populations.
Technology to make medication painless
New drug technologies are seeking to remove the pain and hassle from taking medicine by replacing jabs with breathing and consuming tasty drinks, a report to the Singapore Pharmacy Congress said on Tuesday.
Teva Launches Generic Biaxin; To Refrain From Sales Pending Outcome Of Emergency Motion Filed By Abbot – Update
Teva Pharmaceutical Industries Ltd. (TEVA | charts | news | PowerRating), a generic pharmaceutical company, said on Tuesday that it launched its generic Biaxin or Clarithromycin XL Filmtabs on Friday.
Teva agrees temporary halt of generic antibiotic sale after Abbott court motion
Teva Pharmaceutical Industries Ltd said it has halted sales of its generic antibiotic Clarithromycin, which it launched last Friday, after a court motion brought by Abbott Laboratories.
Court of Appeals Rules in Favor of Teva on Biaxin(R) (Clarithromycin) XL Preliminary Injunction
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the United States Court of Appeals for the Federal Circuit has vacated a June 2005 ruling by the U.S. District Court for the Northern District of Illinois,...